UnitedHealthvsZenas BioPharma

UNH and ZBIO stock compared: price, dividend, valuation and results, from SEC filings.

UNH

UnitedHealth Group Incorporated

$339.85

Value $308B

+2.84%
UNH's page

ZBIO

Zenas BioPharma, Inc.

$23.85

Value $1.6B

-4.75%
ZBIO's page

UnitedHealth (UNH) has a market value of $308B and Zenas BioPharma (ZBIO) $1.6B. Over the last year, with dividends, UNH moved +12.9% and ZBIO -35.8%. Dividend yield: UNH 2.67%, ZBIO none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    UNH$308B

    ZBIO$1.6B

    UNH is 191 times ZBIO

  • Revenue, 12 months

    UNH$450B

    ZBIO$11M

    UNH is 40,878 times ZBIO

  • Net income, 12 months

    UNH$15.9B

    ZBIO-$542M

  • Operating margin

    UNH5.3%

    ZBIO-4,785.5%

    4,790.8 points apart

  • ROIC

    UNH11.3%

    ZBIO-102.7%

    114.0 points apart

  • P/E

    UNH19.4

    ZBIO–

  • Dividend yield

    UNH2.7%

    ZBIO0.0%

    2.7 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

UNH+12.9%

ZBIO-35.8%

50100DecFebAprJunAugOct
Returns by period
PeriodUNHWith dividendsZBIOWith dividends
1 year since November 19, 2025+12.9%Price +10.0%-35.8%Price -35.8%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

UNHUnitedHealthZBIOZenas BioPharma

Valuation

UNHZBIO
Valuation
Price$339.85$23.85
Market value$308B$1.6B
Enterprise value (EV)$354B$1.2B
P/E19.4–
P/E, 5-year median25.0–
P/B3.07.6
EV/EBIT14.8–
Free cash flow yield7.4%–

Results and growth

UNHZBIO
Results and growth
Revenue, 12 months$450B$11M
Net income, 12 months$15.9B-$542M
Free cash flow, 12 months$22.8B-$243M
Earnings per share, 12 months$17.52-$10.05
Revenue growth, year on year11.8%100.0%
Revenue growth a year, past+11.7%over 5 years-55.3%over 2 years
EPS growth a year, past-3.8%over 5 years–

Margins and returns on capital

UNHZBIO
Margins and returns on capital
Gross margin88.3%–
Operating margin5.3%-4,785.5%
Net margin3.5%-4,925.5%
ROIC11.3%-102.7%
ROE15.5%-219.6%

Balance sheet

UNHZBIO
Balance sheet
Cash$28.5B$647M
Total debt$74.3B$225M
Net debt / EBITDA1.6–
Interest cover6.2×-71.8×

Dividends and buybacks

UNHZBIO
Dividends and buybacks
Dividend yield2.7%–
Dividend per share, 12 months$9.06–
Dividend growth a year, past+12.6%over 5 years–
Buyback yield1.8%–
Shareholder yield4.5%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: UNH or ZBIO

Didn't find what you were looking for?

Ask us
Which is bigger, UnitedHealth or Zenas BioPharma?

By market value, UnitedHealth ($308B) is about 190.7 times Zenas BioPharma ($1.6B), at today's prices.

How did UNH and ZBIO stock do over the last 1 years?

Since November 19, 2025, UNH's price moved +10.0% and ZBIO's -35.8%. With dividends: UNH +12.9% (+12.9% a year), ZBIO -35.8% (-35.8% a year). Past returns do not predict future ones.

Which pays the higher dividend, UNH or ZBIO?

The dividend yield at today's price is 2.67% for UnitedHealth and none for Zenas BioPharma. Over the last twelve months they paid $9.06 and – per share.

Which has the higher profit margins, UnitedHealth or Zenas BioPharma?

Over the last twelve months, the net margin was 3.5% for UnitedHealth and -4,925.5% for Zenas BioPharma, and the operating margin 5.3% and -4,785.5%. Revenue was $450B and $11M.

Which is the better investment, UnitedHealth or Zenas BioPharma?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.